Ligand Pharmaceuticals Inc (LGND)
Revenue Per Share
3.17
Quarterly · Period ending:
LGND Revenue Per Share
Latest reported3.17period ending
Latest reported3.17period ending
LGND Quarterly Revenue per Share (0.96 → 3.17)
Period values, visible window
High-resolution chart · PNG
LGND revenue per share history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Revenue Per Share |
|---|---|
| 3.1746 | |
| 2.6013 | |
| 3.0247 | |
| 5.9617 | |
| 2.4643 | |
| 2.3622 | |
| 2.2564 | |
| 2.813 | |
| 2.3037 | |
| 1.747 | |
| 1.6089 | |
| 1.8911 | |
| 1.5262 | |
| 2.5774 | |
| 1.6012 | |
| 3.5067 | |
| 2.9717 | |
| 2.1705 | |
| 4.3311 | |
| 3.8851 | |
| 5.0828 | |
| 3.3556 | |
| 4.3534 | |
| 2.6229 | |
| 2.5799 | |
| 2.0062 | |
| 1.5862 | |
| 1.3217 | |
| 1.2824 | |
| 2.1267 | |
| 2.8281 | |
| 2.1592 | |
| 4.2449 | |
| 2.6478 | |
| 2.4196 | |
| 1.5839 | |
| 1.3323 | |
| 1.3978 | |
| 1.8272 | |
| 1.035 | |
| 0.9492 | |
| 1.4317 | |
| 1.0632 | |
| 0.8901 | |
| 0.9337 | |
| 0.7445 | |
| 1.157 | |
| 0.7334 | |
| 0.5115 | |
| 0.7746 | |
| 0.7209 | |
| 0.6388 | |
| 0.4729 | |
| 0.5771 | |
| 0.6806 | |
| 0.3286 | |
| 0.2907 | |
| 0.286 | |
| 0.6581 | |
| 0.2918 | |
| 0.3798 | |
| 0.1985 | |
| 0.2009 | |
| 0.3975 | |
| 0.2977 | |
| 0.3043 | |
| 0.741 | |
| 0.4195 | |
| 0.4027 | |
| 0.5023 | |
| 0.7783 | |
| 0.3312 | |
| 0.3032 | |
| 0.3077 | |
| 0.3627 | |
| 0.3405 | |
| 0.0847 | |
| 0.014 | |
| 2.5401 | |
| 2.7996 | |
| 3.7011 | |
| 3.9451 | |
| 3.9774 | |
| 3.4508 | |
| 3.7116 | |
| 3.0022 | |
| 3.0079 | |
| 4.0217 | |
| 3.2915 | |
| 2.9969 | |
| 4.89 | |
| 2.6776 | |
| 2.5226 | |
| 1.9752 | |
| 2.3718 | |
| 2.1244 | |
| 1.6332 | |
| 2.3655 | |
| 2.2867 | |
| 1.9309 |